Skip to main content

MoneyWorks4Me

Sai Life Sciences informs about press release

06 Nov 2026 Evaluate
Pursuant to Regulation 30 of SEBI Listing Regulations, Sai Life Sciences has informed that it enclosed the ‘Press Release on Un-audited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September 2026’ being issued by the Company. Further, the above-mentioned press release is also available on the Website of the Company. 

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..